TR200002530A2 - 5-Lipoksijenaz inhibitörlerini üretme usulü. - Google Patents
5-Lipoksijenaz inhibitörlerini üretme usulü.Info
- Publication number
- TR200002530A2 TR200002530A2 TR2000/02530A TR200002530A TR200002530A2 TR 200002530 A2 TR200002530 A2 TR 200002530A2 TR 2000/02530 A TR2000/02530 A TR 2000/02530A TR 200002530 A TR200002530 A TR 200002530A TR 200002530 A2 TR200002530 A2 TR 200002530A2
- Authority
- TR
- Turkey
- Prior art keywords
- naoh
- preparing
- reaction mixture
- aprotic solvent
- producing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Catalysts (AREA)
Abstract
Formül (1.3.0)'a ait bir bilesigin hazirlanmasina yönelik islem tarif edilmistir: buradaki-formüller-dir; su asamalari içerir: asagidakilerden olusan bir reaksiyon karisimimim hazirlanmasi:aprotik bir çözücü içerisinde; NaOH veya KOH varliginda; istege göre bir faz tranfer katalizörü, özellikle de dörtlü bir amonyum tuzu veya bir fosfonyum tuzu varliginda; bunu takiben, bir nitrojen atomosferi altinda adi geçen reaksiyon karisiminin isitilmasi; tercih edilen bir düzenekte aprotik çözücü, DMSO'dur;kati formdaki kuvvetli baz, toz veya topak formunda NaOH'dir, ve faz transfer katalizörü, tetra-n-butilamonyum klorittir (TBAC).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15161099P | 1999-08-31 | 1999-08-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200002530A2 true TR200002530A2 (tr) | 2001-04-20 |
Family
ID=22539510
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2000/02530A TR200002530A2 (tr) | 1999-08-31 | 2000-08-31 | 5-Lipoksijenaz inhibitörlerini üretme usulü. |
Country Status (33)
| Country | Link |
|---|---|
| EP (1) | EP1081144A3 (tr) |
| JP (1) | JP2001106686A (tr) |
| KR (1) | KR20010050274A (tr) |
| CN (1) | CN1286251A (tr) |
| AP (1) | AP2000001909A0 (tr) |
| AR (1) | AR022650A1 (tr) |
| AU (1) | AU5370200A (tr) |
| BG (1) | BG104730A (tr) |
| BR (1) | BR0003888A (tr) |
| CA (1) | CA2316748A1 (tr) |
| CO (1) | CO5180623A1 (tr) |
| CZ (1) | CZ20003159A3 (tr) |
| EA (1) | EA200000803A3 (tr) |
| EE (1) | EE200000513A (tr) |
| GT (1) | GT200000144A (tr) |
| HR (1) | HRP20000565A2 (tr) |
| HU (1) | HUP0003437A3 (tr) |
| ID (1) | ID27128A (tr) |
| IL (1) | IL138089A0 (tr) |
| IS (1) | IS5604A (tr) |
| MA (1) | MA26750A1 (tr) |
| NO (1) | NO20004312L (tr) |
| NZ (1) | NZ506633A (tr) |
| OA (1) | OA11451A (tr) |
| PA (1) | PA8499601A1 (tr) |
| PE (1) | PE20010523A1 (tr) |
| PL (1) | PL342280A1 (tr) |
| SG (1) | SG87145A1 (tr) |
| SK (1) | SK12862000A3 (tr) |
| SV (1) | SV2002000160A (tr) |
| TN (1) | TNSN00176A1 (tr) |
| TR (1) | TR200002530A2 (tr) |
| UY (1) | UY26315A1 (tr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004112837A1 (ja) * | 2003-05-23 | 2004-12-29 | Hisamitsu Pharmaceutical Co., Inc. | 非ステロイド系消炎鎮痛剤含有外用経皮製剤およびインターロイキン－１α生成抑制剤 |
| US7674811B2 (en) | 2006-03-14 | 2010-03-09 | Ranbaxy Laboratories Limited | 5-lipoxygenase inhibitors |
| CN103980312B (zh) * | 2014-05-27 | 2016-09-07 | 广州大学 | 一种n杂环双膦配体及其合成方法 |
| TW202521544A (zh) * | 2023-08-16 | 2025-06-01 | 美商雷瑟拉股份有限公司 | TNFα活性調節劑及其用途 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK281577B6 (sk) * | 1994-10-18 | 2001-05-10 | Pfizer Inc. | Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze |
-
2000
- 2000-08-01 SG SG200004340A patent/SG87145A1/en unknown
- 2000-08-10 PA PA20008499601A patent/PA8499601A1/es unknown
- 2000-08-11 CO CO00060138A patent/CO5180623A1/es not_active Application Discontinuation
- 2000-08-17 EP EP00307046A patent/EP1081144A3/en not_active Withdrawn
- 2000-08-18 OA OA1200000224A patent/OA11451A/en unknown
- 2000-08-24 TN TNTNSN00176A patent/TNSN00176A1/fr unknown
- 2000-08-24 IL IL13808900A patent/IL138089A0/xx unknown
- 2000-08-25 SK SK1286-2000A patent/SK12862000A3/sk unknown
- 2000-08-25 IS IS5604A patent/IS5604A/is unknown
- 2000-08-28 UY UY26315A patent/UY26315A1/es not_active Application Discontinuation
- 2000-08-28 ID IDP20000710A patent/ID27128A/id unknown
- 2000-08-29 AR ARP000104489A patent/AR022650A1/es not_active Application Discontinuation
- 2000-08-29 AU AU53702/00A patent/AU5370200A/en not_active Abandoned
- 2000-08-29 BG BG104730A patent/BG104730A/xx unknown
- 2000-08-29 GT GT200000144A patent/GT200000144A/es unknown
- 2000-08-29 CA CA002316748A patent/CA2316748A1/en not_active Abandoned
- 2000-08-29 PE PE2000000886A patent/PE20010523A1/es not_active Application Discontinuation
- 2000-08-30 SV SV2000000160A patent/SV2002000160A/es unknown
- 2000-08-30 HU HU0003437A patent/HUP0003437A3/hu unknown
- 2000-08-30 BR BR0003888-1A patent/BR0003888A/pt not_active IP Right Cessation
- 2000-08-30 CZ CZ20003159A patent/CZ20003159A3/cs unknown
- 2000-08-30 KR KR1020000050877A patent/KR20010050274A/ko not_active Abandoned
- 2000-08-30 HR HR20000565A patent/HRP20000565A2/hr not_active Application Discontinuation
- 2000-08-30 CN CN00126409A patent/CN1286251A/zh active Pending
- 2000-08-30 NO NO20004312A patent/NO20004312L/no not_active Application Discontinuation
- 2000-08-30 NZ NZ506633A patent/NZ506633A/en unknown
- 2000-08-30 MA MA26053A patent/MA26750A1/fr unknown
- 2000-08-31 EE EEP200000513A patent/EE200000513A/xx unknown
- 2000-08-31 AP APAP/P/2000/001909A patent/AP2000001909A0/en unknown
- 2000-08-31 EA EA200000803A patent/EA200000803A3/ru unknown
- 2000-08-31 PL PL00342280A patent/PL342280A1/xx not_active Application Discontinuation
- 2000-08-31 TR TR2000/02530A patent/TR200002530A2/tr unknown
- 2000-08-31 JP JP2000262200A patent/JP2001106686A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL288365A1 (en) | Method of obtaining derivatives of 1-phenyloimidazolino-2,5-dione | |
| TR200002530A2 (tr) | 5-Lipoksijenaz inhibitörlerini üretme usulü. | |
| PL337894A1 (en) | Method of obtaining 1-aryl-3-cyclopropyl-1,3-propanodiones | |
| EP0242627A3 (en) | An improved process for preparing ester containing organosilicon compounds | |
| IL137119A0 (en) | Process for preparing 2-acetylthio-3-phenyl-propionic acid and the salts thereof | |
| NZ513551A (en) | Novel process for preparing alendronic acid | |
| SI1558560T1 (sl) | Postopek za pripravo 2,6-dihalo-para-trifluorometilanilina | |
| DK1140785T3 (da) | Fremgangsmåde til fremstilling af polyhalogenerede paratrifluormethylaniliner | |
| NO20002214D0 (no) | FremgangsmÕte for syntese av pyrrolaminer | |
| TR200002523A2 (tr) | 5-Lipoksijenaz inhibitörleri yapma yöntemi | |
| RU97101086A (ru) | Усовершенствованный способ аминирования пиридиновых оснований по чичибабину | |
| PL337906A1 (en) | Method of obtaining derivatives of 2-alkyl thiobenzoic acid | |
| AU574124B2 (en) | Preparation of o-isopropoxyphenol | |
| ES8306364A1 (es) | "procedimiento para la preparacion de un derivado de 1,4-dehidropirimidina". | |
| JPS5473775A (en) | Isoxazoline-3-one derivative | |
| KR830009093A (ko) | 티오알킬아미드 및 1-옥시드 니코틴산 및 그의 염의 제조방법 | |
| JPS5520719A (en) | Preparation of 1,4-dihydropyridine derivative | |
| JPS5640622A (en) | Procution of vinylidene halide | |
| DK0483674T3 (da) | Fremgangsmåde til fremstilling af et alifatisk amid og salte deraf | |
| JPS57185247A (en) | 4-halo-2-hexenoic acid amide derivative, its preparation and herbicide containing the same | |
| DK0944600T3 (da) | Fremgangsmåde til omdannelse af hydroxy-heteroaromater til arylaminer | |
| JPS54145633A (en) | Preparation of 2,6-dicyanophenol derivative | |
| JPS54145632A (en) | Preparation of 2-cyanophenol derivative | |
| JPS5572190A (en) | Preparation of 1-(5'-oxohexyl)-3,7-dimethyl-xanthine | |
| ES448908A1 (es) | Un procedimiento para la preparacion de nicotinoilcarniti- na. |